Related by context. All words. (Click for frequent words.) 67 neuropsychiatric events 67 neuropsychiatric adverse 65 clevidipine 64 kidney urologic 64 myopathy rhabdomyolysis 64 AA Amyloidosis 64 acyclovir valacyclovir 63 Hepatotoxicity 63 Teriflunomide 63 severe hypersensitivity reactions 62 cerivastatin 62 PROactive study 62 hypersensitivity allergic reactions 62 non cirrhotic portal 62 stroke hypertension palpitations 62 Tardive dyskinesia 62 AVERROES 62 haematologic 62 neuropsychiatric symptoms 62 demyelinating 62 thromboembolic disease 62 paroxetine Seroxat 61 Celebrex celecoxib 61 nasopharyngitis headache 61 thrombo embolic 61 Torsades de Pointes 61 Warfarin Coumadin 61 neratinib 61 Known hypersensitivity 61 ThermoDox ® clinical 61 Myfortic 61 cerebrovascular adverse 61 cardiac repolarization 61 syncope fainting 61 atypical femur fractures 61 vismodegib 61 aseptic meningitis 60 meta regression 60 FluCAM arm 60 pregabalin Lyrica 60 coagulation disorders 60 REMINYL ® 60 GSK Avandia 60 Multivariate logistic regression 60 pediatric bipolar disorder 60 MAGE A3 ASCI 60 sJIA 60 relapsed MCL 60 heparin induced thrombocytopenia 60 thorough QT 60 Afatinib 60 QTc prolongation 60 oral mTOR inhibitor 60 containing LABAs 60 Eraxis 60 cardiovascular ischemic 60 non selective NSAIDs 60 GERD migraine headaches 60 prospective observational studies 60 thalidomide Thalomid 60 efalizumab 60 Serious Adverse Events 60 thrombotic thrombocytopenic purpura TTP 60 Nasdaq ONXX today 60 Subgroup analyzes 60 paliperidone ER 60 midstage clinical 60 AGGRASTAT R tirofiban hydrochloride 60 atherosclerotic cardiovascular 60 RISPERDAL ® 60 Fingolimod 60 risperidone Risperdal 60 bovine thrombin 60 relapsed MM 60 poststroke depression 60 antiepileptics 60 topical calcineurin inhibitors 60 toxicologic 60 neuropsychiatric 60 neuro developmental disorders 59 eosinophilic pneumonia 59 dyslipidemia hypertension diabetes 59 constipation OIC 59 varicella infection 59 prospective multicentre 59 PDE# inhibitors 59 preclinical efficacy 59 Sibutramine Cardiovascular Outcomes 59 syncopal 59 STRIDE PD 59 tolerability profiles 59 anaphylactoid 59 NNT = 59 Zometa zoledronic acid 59 pancytopenia 59 BEXXAR Therapeutic Regimen 59 pulls Darvon painkiller 59 included exfoliative dermatitis 59 AGGRASTAT ® tirofiban hydrochloride 59 erythema nodosum 59 headache abdominal pain 59 developmental neurotoxicity 59 EEG abnormalities 59 KETEK 59 cardiovascular thrombotic 59 anti IgE antibody 59 Multiple logistic regression 59 postmarketing surveillance 59 genomic biomarker 59 Cariprazine 59 sibutramine Meridia 59 cardio metabolic diseases 59 invasive candidiasis 59 prelicensure 59 statins cholesterol lowering 59 YONDELIS 59 riociguat 59 Carotid Revascularization Endarterectomy vs. 59 PLAVIX ® 59 dyslipidaemia 59 Phase IIb III 59 Triapine R 59 blood dyscrasias 59 fusion enhancers 59 hepatic toxicity 59 tiagabine 59 antiplatelet medications 59 antirheumatic 59 infliximab Remicade 59 renal toxicity 59 anaphylactic reactions bronchospasm 59 Henoch purpura 59 Carbamazepine 59 intracerebral haemorrhage 59 ADVEXIN therapy 59 CIMZIA TM certolizumab pegol 59 genotypic resistance 59 atherothrombotic 59 mitochondrial toxicity 59 ZOLINZA 59 Primary endpoints 58 FDA Adverse Event 58 biostatistical analysis 58 inhaled bronchodilators 58 teriflunomide 58 venous thromboembolic disease 58 torcetrapib atorvastatin 58 gepirone ER 58 extrapyramidal symptoms 58 Pimavanserin 58 headache nasopharyngitis 58 postmarket surveillance 58 Thalomid ® 58 postapproval 58 desvenlafaxine succinate 58 paroxetine sertraline 58 Erythropoietic therapies may 58 hematological adverse 58 SPIRIVA HandiHaler 58 ischemic cardiac 58 MYCAMINE 58 DVT PE 58 pharmaco vigilance 58 bardoxolone methyl 58 plasma kallikrein inhibitor 58 pioglitazone hydrochloride 58 ACTOS ® 58 neovascular diseases 58 Postmarketing 58 ARCOXIA 58 tremors anxiousness depression 58 Secondary efficacy endpoints 58 agomelatine 58 Evoltra ® 58 NP2 Enkephalin 58 number NCT# ClinicalTrials.gov 58 acute myocardial infarction MI 58 Teplizumab 58 HMG CoA reductase inhibitors 58 rheumatoid arthritis osteoarthritis ankylosing 58 TMS Therapy 58 Hematologic 58 PML progressive multifocal 58 paroxetine Paxil 58 Observational studies 58 tamoxifen Nolvadex ® 58 Equetro 58 preclinical pharmacology 58 cytomegalovirus infection 58 SILENOR 58 Cancidas 58 piroxicam 58 Rilonacept 58 influenza antiviral medications 58 preclinical pharmacokinetic 58 thetreatment 58 Vimpat R 58 thiazolidinedione TZD 58 cardiovascular cerebrovascular 58 gemifloxacin 58 unmeasured confounders 58 INVANZ 58 tumor subtypes 58 fulminant hepatitis 58 postoperative AF 58 ischemic cardiovascular 58 psoriasis Crohn disease 58 cryosurgical treatment 58 varenicline Chantix 58 ß blockers 58 AML MDS 58 CYT# potent vascular disrupting 58 KIF6 carriers 58 tegaserod 58 ASPIRE HIGHER 58 Bextra valdecoxib 58 cutaneous lupus 58 Geodon ziprasidone 58 torsades de pointes 58 mania hypomania 58 aspirin clopidogrel 58 Febrile neutropenia 58 MabThera rituximab 58 Nephros DSUs 58 GSK# [001] 58 HeFH 58 neutropenia dehydration dyspnea 58 Raptiva R 58 immunotoxicity 58 tardive dyskinesia TD 58 HER2 overexpression 58 parecoxib 58 mild hepatic impairment 58 ARCALYST ® 58 Amgen denosumab 58 indicates cardio circulatory 58 pharmacologic therapies 58 radiolabeled TM# 58 Accolate 58 myocardial infarction ventricular fibrillation 58 serious neuropsychiatric symptoms 58 ADVERSE EVENTS 58 MGd 58 Paliperidone ER 58 samalizumab 58 pharmacologic stress 58 ziconotide 58 Bioaccelerate compounds under 58 lucinactant 58 influenzalike illness 58 either acutely decompensated 58 pharmacodynamic parameters 58 Prostate Px + 58 erythropoietic 58 novel oral anticoagulant 58 dysrhythmias 58 teratogenic 58 arterial thrombotic 58 postexposure prophylaxis 57 nonhematologic adverse reactions 57 p# biomarker 57 hematological toxicities 57 casopitant 57 idiopathic thrombocytopenic purpura 57 prognostic biomarkers 57 Disease ILD 57 Fanconi syndrome 57 Phase IIIB IV 57 Liprotamase 57 BARI 2D 57 NPM1 mutation 57 mucocutaneous reactions 57 recurrent DVT 57 anaphylactoid reactions 57 recurrent glioblastoma multiforme 57 Plaquenil 57 nonvaccine 57 venlafaxine XR 57 tularemia infections 57 cerebral microbleeds 57 Velcade bortezomib 57 vaccine RotaTeq 57 enteroviral infection 57 Aggrastat ® tirofiban hydrochloride 57 antiplatelet therapies 57 comorbid psychiatric disorders 57 hemorrhagic cystitis 57 Aryplase 57 Silodosin 57 COPEGUS therapy 57 tramiprosate Alzhemed TM 57 deCODE AF TM 57 antiepileptic drug 57 Vectibix panitumumab 57 metaanalysis 57 antiarrhythmic drug 57 SNT MC# 57 acute phosphate nephropathy 57 hepatic failure 57 nociceptive pain 57 Helicobacter pylori eradication 57 Pentacel vaccine 57 torsemide ER 57 Pseudomonas aeruginosa infections 57 comorbid depression 57 LibiGel ® testosterone gel 57 Mesafem 57 SPRIX ® 57 IMiDs ® compound 57 BEXXAR 57 optic neuropathy NAION 57 Cardiotoxicity 57 anticonvulsant medication 57 pharmacokinetic interactions 57 Symptom severity 57 aripiprazole Abilify 57 cSSSIs 57 leukotriene receptor antagonists 57 Severe Primary IGFD 57 basal bolus regimen 57 Tß4 57 gastrointestinal perforations 57 TMP SMX 57 ticagrelor Brilinta 57 Meta analyzes 57 olanzapine LAI 57 Fibrillex TM 57 SSRI SNRI 57 chromium picolinate supplementation 57 Tasigna prolongs 57 Effexor venlafaxine 57 Multivariable logistic regression 57 clinico pathological 57 liver transaminases 57 autoimmune reactions 57 randomized discontinuation trial 57 convulsive disorders 57 rheumatological 57 containing abacavir 57 Tarceva TM 57 antithrombotic therapies 57 MGCD# clinical trials 57 oral methylnaltrexone 57 blood coagulation disorders 57 genitourinary GU 57 albiglutide 57 CYP#D# inhibitor 57 atherothrombotic disease 57 management biostatistical analysis 57 gonococcal 57 neuroleptic 57 intravenous bisphosphonates 57 Cimzia TM 57 SPARLON 57 APEX AMI trial 57 cardio renal 57 serious cardiovascular thrombotic 57 pulmonary infiltrates 57 receiving VELCADE 57 necrotizing pancreatitis 57 P#X# antagonist 57 deferiprone 57 pathogenetic mechanisms 57 eprodisate Fibrillex TM 57 uridine triacetate 57 orally inhaled migraine 57 KAPVAY ™ 57 aldosterone antagonist 57 MEVACOR 57 Zenvia ™ 57 ATACAND 57 biologic DMARD 57 teratogenicity 57 ROTARIX 57 torsade de pointes 57 symptomatic intracranial 57 aldosterone antagonists 57 Relapsing remitting MS 57 immunomodulation 57 NSF NFD 57 renal scarring 57 Prosaptide 57 pulmonary toxicity 57 coinfected patients 57 Renal Cell Carcinoma RCC 57 IBS C 57 hepatotoxic 57 dose proportionality 57 HCV antibody 57 bronchopulmonary dysplasia BPD 57 Reversible Posterior Leukoencephalopathy Syndrome 57 rosuvastatin Crestor 57 Clinicaltrials.gov 57 chronic thromboembolic pulmonary 56 MERLIN TIMI 56 eculizumab therapy 56 somnolence dizziness 56 cytopenia 56 Cinquil 56 banned Darvon Darvocet 56 fluoxetine paroxetine 56 prenatal exposures 56 Tolvaptan 56 tumor histology 56 patientswith 56 LEVAQUIN 56 coronary insufficiency 56 Heavy snorers 56 dermatologic reactions 56 NATRECOR ® 56 Perforomist ™ Inhalation Solution 56 EXJADE 56 reactogenicity 56 rufinamide 56 thromboembolic complications 56 CHAMPION PCI 56 INFERGEN 56 treat chronic sinusitis 56 Embolic Protection Device 56 ToGA 56 orofacial clefts 56 ruboxistaurin 56 esophageal reflux 56 Vaprisol 56 interstitial pneumonia 56 CTEPH 56 prolonged QT interval 56 idiopathic pulmonary 56 respiratory gastrointestinal 56 sporadic Creutzfeldt Jakob 56 Dementia Related Psychosis 56 antidepressants fluoxetine 56 journal Cephalalgia 56 SJS TEN 56 hepatic insufficiency 56 guanfacine extended release 56 Telintra 56 HCV protease inhibitors 56 pain palliation 56 Raptiva ® 56 Tumor Response 56 antiphospholipid syndrome 56 NHAMCS 56 panitumumab Vectibix 56 trastuzumab emtansine T DM1 56 Pyridorin 56 Starlix 56 methodological limitations 56 vaginally administered lidocaine 56 post herpetic neuralgia PHN 56 alemtuzumab treated 56 PNH patients 56 neuro degenerative disorders 56 visilizumab 56 prognostic indicators 56 CELVAPAN H#N# 56 Adentri 56 myeloproliferative diseases 56 etiologic 56 VaD 56 anticholinergic effects 56 Paxil paroxetine 56 bone marrow suppression 56 receiving XGEVA 56 Multaq dronedarone 56 CaPSURE 56 platelet aggregation inhibitors 56 ziprasidone Geodon 56 ORENCIA ® 56 diarrhea vomiting nausea 56 neutropenia thrombocytopenia 56 Phase IIIb study 56 idiopathic thrombocytopenic purpura ITP 56 Avandia Actos 56 symptomatic pulmonary embolism 56 lipid lowering medication 56 parkinsonian symptoms 56 Revimmune TM 56 Prexige lumiracoxib 56 chronic urticaria 56 papillary renal cell carcinoma 56 Noxafil 56 diabetic kidney 56 unresectable HCC 56 simvastatin ezetimibe 56 #F FDG PET 56 alpha interferons 56 indications contraindications 56 oxypurinol 56 thromboembolic events 56 syndromic 56 AGHD 56 elevated ALT 56 chronic idiopathic thrombocytopenic purpura 56 GI motility disorders 56 acute coronary syndromes ACS 56 ocular adverse 56 Val HeFT 56 haloperidol Haldol 56 Kepivance 56 intracranial stenosis 56 immunodeficiencies 56 Comorbid 56 PRADAXA 56 RAPTIVA 56 arboviral 56 biologic DMARDs 56 hepatotoxicity 56 ACCORD Lipid 56 brivaracetam 56 tipranavir ritonavir 56 hoFH 56 escitalopram Lexapro 56 levodopa induced 56 EDEMA3 trial 56 NAEPP 56 vascular endothelial dysfunction 56 Leber Hereditary Optic Neuropathy 56 enterovirus infections 56 headache arthralgia 56 induced hepatotoxicity 56 Adverse effects 56 wilate ® 56 Darapladib 56 Natalizumab 56 Canvaxin 56 stratifying patients 56 empiric therapy 56 elotuzumab 56 Androxal TM 56 TYSABRI treated 56 hyperacute 56 Infusion Reactions Severe 56 hemodynamic measurements 56 Saforis 56 retrospective cohort 56 EFFEXOR XR 56 cobiprostone 56 motesanib 56 PDSS 56 Zalypsis 56 Serological 56 alfuzosin 56 CRMD# 56 Ritalin methylphenidate 56 UCB Cimzia 56 Candesartan 56 renoprotective 56 smoldering myeloma 56 Treatment emergent adverse 56 quinolone antibiotic 56 intensive statin therapy 56 Potiga 56 symptomatic hyponatremia 56 INVEGA ® 56 Efficacy endpoints 56 thoracic aortic disease 56 RoACTEMRA 56 RE LY trial 56 barbiturates benzodiazepines 56 pharmacologic treatments 56 angiographically 56 angioedema 56 Mg Usa 56 fatal hemorrhagic 56 Gastrointestinal GI 56 urolithiasis 56 intranasal corticosteroid 56 clinicopathological 56 PRIMO CABG2 56 venlafaxine Effexor 56 triglyceride lowering 56 neuro psychiatric disorders 56 Rheos System 56 MGN# 56 treatment emergent hyperglycemia 55 Adverse Event 55 comorbid ADHD 55 CONBRIZA 55 severe hepatic dysfunction 55 Iressa gefitinib 55 Magnesium deficiency 55 longitudinal observational study 55 Canvaxin TM 55 neurocognitive impairment 55 denileukin diftitox 55 canakinumab 55 follicular adenoma 55 Selective Serotonin Reuptake Inhibitor 55 neurocognitive functioning 55 Major Depressive Disorder MDD 55 Vernakalant 55 urate lowering 55 prognostic variables 55 CANCIDAS 55 ocular infections 55 hematopoietic cancers 55 causative pathogen 55 headache vomiting 55 Wellbutrin bupropion 55 sNDA submission 55 unknown etiology 55 ADAGIO study 55 pharmacodynamic markers 55 Hypotension 55 CARE HF 55 hypersensitivity reactions 55 endocrinologic 55 invasive aspergillosis 55 posaconazole 55 somatostatin analogues 55 Focalin XR 55 refractory gout 55 QT prolongation 55 malignant neoplasms 55 Levetiracetam 55 antithrombotic therapy 55 lomitapide 55 hallucinations delirium 55 demyelinating disease 55 HQK 55 noncardiovascular 55 Naproxen sodium 55 parasitological 55 Tigecycline 55 Selective Serotonin Re 55 phototoxicity 55 Screening Trial DMIST 55 hyperphenylalaninemia HPA due 55 KRAS status 55 Egrifta 55 pulmonary hypertension PH 55 renal dysfunction acute renal 55 lipohypertrophy 55 alemtuzumab MS 55 Product Monograph 55 seizures comas 55 Hepatocellular Carcinoma HCC 55 oxymorphone ER 55 ZOMIG 55 neuropsychological evaluations 55 pioglitazone HCl 55 quetiapine Seroquel 55 Atypical antipsychotics 55 inflammatory biomarkers 55 APPRAISE 55 thiazolidinediones TZDs 55 immunological diseases 55 neuropathic pain spasticity 55 ALK inhibitors 55 vascular insufficiency 55 Tygacil 55 alpha1 antitrypsin deficiency 55 eprotirome 55 Medwatch 55 Tracleer R 55 Angioedema 55 postoperative ileus POI 55 serologic testing 55 pharmacogenetic testing 55 ACOMPLIA R 55 lipid lowering therapies 55 gadobutrol 55 nalbuphine ER 55 Zeldox 55 pharmacoeconomic 55 ECG abnormalities 55 blinded randomized placebo controlled 55 clobazam 55 Abdominal ultrasound 55 pathologic fractures 55 anti JCV antibodies 55 PCNSL 55 Trandolapril 55 telithromycin 55 Dr. Gabriel Lasala 55 GlaxoSmithKline Paxil 55 serotonin norepinephrine reuptake inhibitor 55 Auxilium anticipates 55 Venous thromboembolism 55 oxcarbazepine 55 pharmacodynamic effects 55 Progressive Multifocal Leukoencephalopathy PML 55 oral antidiabetes drugs 55 balsalazide tablet 55 efficacy tolerability 55 Lipitor #mg 55 RELOVAIR ™ 55 ImmuKnow R 55 herpes zoster vaccine 55 r hGH 55 beta carotene supplementation 55 cardiac valvulopathy 55 Quinamed 55 gastrointestinal perforation 55 Lumiracoxib 55 neuroleptic malignant syndrome 55 oseltamivir resistance 55 NOMID 55 GH deficiency 55 Anzemet 55 anticholinergic agents 55 ViaDerm hPTH #-# 55 Zoloft sertraline 55 NEUVENGE 55 thromboembolic 55 leukotriene receptor antagonist 55 hepatic lesions 55 CAMMS# 55 TRISENOX 55 macrovascular events 55 C. sordellii 55 INTEGRILIN 55 extrapulmonary disease 55 adrenal suppression 55 CP CPPS 55 NIASPAN 55 antithrombotic agents 55 Serious AEs 55 Danazol 55 hypothalamic pituitary adrenal axis 55 Bcr Abl mutations 55 jaw osteonecrosis 55 Tesmilifene 55 Cancer Incidence Mortality 55 Lactic acidosis 55 levetiracetam Keppra 55 Glatiramer acetate 55 OHR/AVR# 55 Sycrest 55 Electrophysiological 55 bullous 55 histamine dihydrochloride 55 bevirimat Study 55 BoNTA 55 Sporanox 55 interferon gamma 1b 55 varespladib 55 CNS depressant 55 cardiotoxic 55 vaccinees 55 plasma pharmacokinetics 55 pegnivacogin 55 Genetic variants 55 monoclonal antibody therapeutics 55 K ras mutations 55 FACTIVE R gemifloxacin 55 symptomatic paroxysmal AF 55 gallium nitrate 55 antipsychotic prescribing 55 memantine HCl 55 Panzem ® 55 Spiriva Handihaler 55 TYGACIL 55 immunotherapeutic approaches 55 SIADH 55 conivaptan 55 urticaria hives 55 flecainide 55 zileuton IV 55 ximelagatran 55 antiangiogenic therapy 55 intravenous methylnaltrexone 55 cystic fibrosis chronic pancreatitis 55 hypercalcemia 55 angioneurotic edema 55 cerebral vasospasm 55 Chantix varenicline 55 EGS# 55 Vesivirus 55 Risperdal risperidone 55 endothelin antagonist 55 cytomegalovirus CMV retinitis 55 CAMPATH 55 subthreshold depression 55 USpella 55 prolactin elevation 55 antiangiogenic agent 55 retrospective cohort study 55 valvular heart disease 55 Sodium oxybate 55 FFR measurements 55 Renal impairment 55 Budesonide foam crofelemer 55 Invirase saquinavir 55 MediGene focuses 55 hepatorenal syndrome 55 inhaled iloprost 55 Dr. Assa Amit 55 G6PD deficiency 55 staphylococcal vaccine 55 TQT studies 55 neuropathologic 55 COPD exacerbations 55 gastrointestinal GI 55 CYP#A# substrate 55 vasogenic edema 55 didanosine associated 55 mycosis fungoides 55 dose escalation phase 55 arterial thromboembolic 55 Staph aureus infections 55 acute respiratory tract infections 55 discontinued Viread 55 TASKi3 55 hematological toxicity 55 desvenlafaxine 55 primidone 55 retrospective observational 55 fluvastatin 55 Regranex 55 IV acetaminophen 55 unresectable tumors 55 ischemic colitis 55 lipid parameters 55 biochemical abnormalities 55 APEX AMI 55 Meridia sibutramine 55 UVIDEM 55 Vaxfectin TM 55 bi polar disorders 55 investigational therapies 55 liver toxicity 55 Serious allergic reactions 55 Levamisole 55 journal Epilepsia 55 atherothrombosis 55 thrombotic events 55 Vidaza azacitidine 55 behavioral disturbances 55 Zolpimist ™ 55 coexisting illnesses 55 Thrombotic events 55 clinically asymptomatic 55 NATRECOR R 55 Telithromycin 54 Oracea TM 54 Subgroup analysis 54 Dr. Kandzari 54 sertraline Zoloft 54 MenACWY CRM 54 ecotoxicological 54 pravastatin Pravachol 54 Perfusion CT 54 GENASIS 54 gastrointestinal adverse reactions 54 florbetaben 54 subchronic 54 GRNCM1 54 haematological 54 MelaFind R 54 zafirlukast 54 myeloproliferative 54 Neupro R 54 TNF antagonist 54 Alzheimer disease cognitive impairment 54 retrovirus XMRV 54 acute mania 54 HORIZONS AMI 54 SYN# 54 Hypocalcemia 54 meta analysis pooling 54 associated diarrhea CDAD 54 hepatic dysfunction 54 nodal metastasis 54 CINQUIL 54 psychopharmacological 54 RhuDex R 54 HIV HCV coinfected 54 lenalidomide dexamethasone 54 antiretroviral naïve 54 LEVADEX ™ 54 chlamydial infections 54 lipid lowering agents 54 postoperative pulmonary 54 OsmoPrep 54 TACI Ig 54 Urocortin 2 54 serious Interstitial Lung 54 protease inhibitors PIs 54 pelvic malignancies 54 SRBD 54 functional neuroimaging 54 platelet dysfunction 54 tumor lysis syndrome 54 vidofludimus 54 Mellaril 54 EXPLORE Xa 54 inhaled budesonide 54 AERx iDMS 54 prodrug stimulant 54 Prozac fluoxetine 54 PR interval prolongation 54 dietary acrylamide 54 glitazone class 54 dyslipidemias 54 antimuscarinic 54 MEND CABG 54 preclinically 54 neurologic symptoms 54 receptor inhibitor 54 ACOSOG Z# 54 vertigo dizziness 54 nonaspirin 54 prospective nonrandomized 54 Combunox 54 variant angina 54 hyperprolactinemia 54 immunologic responses 54 atrial arrhythmias 54 Zyprexa olanzapine 54 quetiapine fumarate 54 Quetiapine 54 intranasal corticosteroids 54 AFRS TM 54 molecular biomarker 54 cytopenias 54 QT interval prolongation 54 Valproate 54 immune thrombocytopenic purpura ITP 54 myocardial infarctions MIs 54 Firazyr 54 antiepileptic medications 54 subclinical disease 54 intravenous acetaminophen 54 Zevalin consolidation 54 ADEs 54 Suicidal ideation 54 leukoencephalopathy 54 nitrofurantoin 54 RH1 54 allogeneic HSCT 54 Cleviprex TM clevidipine 54 placebo controlled clinical 54 including eniluracil ADH 54 Drospirenone 54 pulmonary artery catheterization 54 acetaminophen paracetamol 54 ezetimibe simvastatin 54 OVATURE 54 noncardiac chest pain 54 Benlysta belimumab 54 rimonabant Acomplia 54 serum phosphorous 54 non valvular atrial 54 STEP BD 54 lumiracoxib 54 SJIA 54 juvenile idiopathic arthritis 54 PLX STROKE targeting 54 Aprotinin 54 Savella TM 54 Clinically significant 54 bepotastine besilate nasal spray 54 cellular immunotherapy 54 newer atypical antipsychotics 54 exploratory endpoints 54 inflammation metabolic disorders 54 chronic noncancer pain 54 upper gastrointestinal bleeding 54 TNF blocker therapy 54 Diastolic Heart Failure 54 ularitide 54 demyelinating disorders 54 BioMAP 54 MMRV vaccine 54 Entereg R 54 neuro psychiatric 54 symptom flare ups 54 maximally tolerated lipid lowering 54 Dapoxetine 54 cerebral oximetry 54 Vizilite 54 Postherpetic neuralgia PHN 54 granulomatous 54 overlapping toxicities 54 delayed CINV 54 LungAlert TM 54 Accutane isotretinoin 54 rosiglitazone maleate 54 polyarticular 54 LAS# [002] 54 ALVESCO HFA 54 prostate cancer CaP 54 Serious adverse reactions 54 penicillin allergy 54 intracerebral hemorrhage 54 hypertension palpitations 54 colorectal adenoma 54 biomarker identification 54 Zemplar Capsules 54 CHD CVD 54 myocardial revascularization 54 Inhaled nitric oxide 54 acetaminophen poisoning 54 GnRH antagonists 54 anaphylactoid reaction 54 Selective Electrochemical Tumor Ablation 54 danazol